MedTrace Logo

Longitudinal Study for Central Nervous System Vasculitis

NCT05734404 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2026-01-23

No results posted yet for this study

Summary

Primary central nervous system vasculitis (CNSV) is a potentially fatal, single-organ vasculitis that often involves a spectrum of neurologic complications, including strokes, cognitive and speech impairment, visual loss, dementia, and encephalopathy. The purpose of this study is to establish a research cohort to investigate the disease process, treatments, and patient outcomes in CNSV.

Conditions

  • Central Nervous System Vasculitis
  • CNS Vasculitis
  • CNSV
  • Vasculitis

Sponsors & Collaborators

Principal Investigators

  • Rula Hajj-Ali, MD · The Cleveland Clinic

  • Leonard Calabrese, MD · The Cleveland Clinic

  • Peter Merkel, MD · University of Pennsylvania

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05734404 on ClinicalTrials.gov